- Home
- OPK vs ADAM Comparison
OPK vs ADAM Comparison
Compare OPK & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | ADAM |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | 221 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 789.9M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | OPK | ADAM |
|---|---|---|
| Price | $1.29 | $8.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.60 | ★ $9.17 |
| AVG Volume (30 Days) | ★ 2.3M | 858.1K |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | $5.08 |
| P/E Ratio | ★ N/A | $41.51 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $6.45 |
| 52 Week High | $1.60 | $9.32 |
Technical Indicators
Market Signals| Indicator | OPK | ADAM |
|---|---|---|
| Relative Strength Index (RSI) | 71.83 | 61.48 |
| Support Level | $1.28 | $7.72 |
| Resistance Level | $1.42 | $9.23 |
| Average True Range (ATR) | 0.04 | 0.22 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 93.33 | 67.21 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About ADAM Adamas Trust Inc.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.